课题基金 / 基金详情

Mechanisms of gene amplification in human cancers

Mechanisms of gene amplification in human cancers
人类癌症基因扩增的机制
批准号:
10466882
负责人:
Hisashi Tanaka
金额:
$35.61万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2023-08-31

项目摘要

项目成果

Hisashi Tanaka的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 我们的研究目标是确定结构染色体的机制 异常和人类肿瘤中的基因组扩增。基因组(基因)扩增是关键之一 肿瘤发展和进展的驱动因素。有几个,复发扩增的癌基因位点,在 基因组巨大的努力已经指向对抗癌基因扩增的结果,例如 作为过度表达的蛋白质和下游信号通路。到目前为止,很少有人注意到 潜在的放大机制的翻译潜力。我们的长期目标是将 基因组扩增机制的知识,用于控制侵袭性肿瘤。 携带癌基因的基因组片段可以在染色体内积累, 在染色体外以圆形微型染色体的形式存在。因此,确定单个分子过程 控制基因组扩增似乎是一个挑战。我们已经证明,DNA复制中的缺陷是 基因组扩增的关键起始事件。为了忠实地复制大型人类基因组, 机器(叉子)必须走很长的距离,并克服一些自然障碍,如DNA 二级结构和与转录机制的碰撞。肿瘤细胞和癌前病变通常 无法在这些障碍处保护复制分叉,因此,分叉停止并崩溃(复制压力)。 折叠的分叉变成断裂的分叉,带有重组DNA末端,这可能导致染色体断裂。 异常和基因组扩增。 虽然我们现在认识到复制应激的关键作用,但从停滞/崩溃到崩溃的分子机制, 重复基因组扩增的分叉仍然难以捉摸。这些信息对于确定新的目标至关重要, 控制基因组扩增。要发生反复的基因组扩增, 在一个癌基因附近,反复阻碍复制叉的运动。我们假设基因座特异性, 自然的基因组压力阻碍复制叉的运动,并护送崩溃的叉进入复发的基因组。 放大我们在两个反复扩增的基因组位点,8 q24与MYC, 癌基因(AIM 1)和17 q12 -21与ERBB 2癌基因(AIM 2),并将研究分子机制 从停滞/崩溃的分叉到基因组扩增的一步一步。我们的结果将揭示一种特定的相互作用 扩增机制和局部基因组背景之间的联系,这可能为我们提供一种新的机制, 具有治疗潜力的洞察力。
英文摘要
PROJECT SUMMARY The goal of our proposed study is to determine the mechanisms underlying structural chromosome abnormalities and genomic amplification in human tumors. Genomic (gene) amplification is one of the key drivers of tumor development and progression. There are several, recurrently amplified oncogene loci in the genome. Enormous efforts have been directed to antagonizing the outcomes of oncogene amplification, such as overexpressed proteins and downstream signaling pathways. So far, little attention has been paid to the translational potential of the underlying amplification mechanisms. Our long-term goal is to translate the knowledge from genomic amplification mechanisms for controlling aggressive tumors. A genomic segment harboring an oncogene can accumulate either within chromosomes or extrachromosomally in the form of circular minichromosomes. Therefore, identifying a single molecular process for controlling genomic amplification appears challenging. We have shown that a defect in DNA replication is a crucial initiating event for genomic amplification. To faithfully duplicate the large human genome, replication machinery (forks) must travel a long distance and overcome a number of natural obstacles, such as DNA secondary structures and collisions with transcription machinery. Tumor cells and pre-cancerous lesions often fail to protect replication forks at these obstacles, and as a result, forks stall and collapse (replication stress). Collapsed forks become broken forks with recombinogenic DNA ends, which can lead to chromosomal abnormalities and genomic amplification. Although we now recognize the crucial role of replication stress, molecular mechanisms from stalled/collapsed forks to recurrent genomic amplification remain elusive. Such information is essential to identify new targets to control genomic amplification. For recurrent genomic amplification to occur, there must be a natural obstacle near an oncogene that repeatedly impedes replication fork movements. We hypothesize that locus-specific, natural genomic stress impedes replication fork movements and escorts collapsed forks into recurrent genomic amplification. We have identified candidate obstacles in two recurrently-amplified genomic loci, 8q24 with MYC oncogene (AIM1) and 17q12-21 with ERBB2 oncogene (AIM2), and will investigate molecular mechanisms step-by-step from stalled/collapsed forks to genomic amplification. Our results will reveal a specific interaction between amplification mechanisms and local genomic context, which may provide us a novel mechanistic insight with therapeutic potential.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Mutant POLQ and POLZ/REV3L DNA polymerases may contribute to the favorable survival of patients with tumors with POLE mutations outside the exonuclease domain.
突变的 POLQ 和 POLZ/REV3L DNA 聚合酶可能有助于外切核酸酶结构域外具有 POLE 突变的肿瘤患者的良好生存。
DOI: 10.1186/s12881-020-01089-9
发表时间: 2020
期刊: BMC medical genetics
影响因子: --
作者: [Huang,Fangjin, Tanaka,Hisashi, Knudsen,BeatriceS, Rutgers,JoanneK]
通讯作者: Rutgers,JoanneK
DOI: 10.1186/bcr3362
发表时间: 2012-11-26
期刊: Breast cancer research : BCR
影响因子: --
作者: [Marotta M, Chen X, Inoshita A, Stephens R, Budd GT, Crowe JP, Lyons J, Kondratova A, Tubbs R, Tanaka H]
通讯作者: Tanaka H
DOI: 10.1016/j.critrevonc.2022.103725
发表时间: 2022-05
期刊: Critical reviews in oncology/hematology
影响因子: --
作者: [F. Igari;Hisashi Tanaka;A. Giuliano]
通讯作者: F. Igari;Hisashi Tanaka;A. Giuliano
DOI: 10.1371/journal.pone.0038958
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者: [Marotta M, Piontkivska H, Tanaka H]
通讯作者: Tanaka H
共 8 条
    Small circular DNA as a signature of defects in DNA replication control
    • 批准号:
      8958670
    • 项目类别:
    • 资助金额:
      $8.75万
    • 财政年份:
      2015
    • 负责人:
      Hisashi Tanaka
    • 依托单位:
    DNA inverted repeats as an at-risk motif for palindromic gene amplification
    • 批准号:
      8459008
    • 项目类别:
    • 资助金额:
      $29.7万
    • 财政年份:
      2010
    • 负责人:
      Hisashi Tanaka
    • 依托单位:
    DNA inverted repeats as an at-risk motif for palindromic gene amplification
    • 批准号:
      8256527
    • 项目类别:
    • 资助金额:
      $31.6万
    • 财政年份:
      2010
    • 负责人:
      Hisashi Tanaka
    • 依托单位:
    Mechanisms of gene amplification in human cancers
    • 批准号:
      10241284
    • 项目类别:
    • 资助金额:
      $36.34万
    • 财政年份:
      2010
    • 负责人:
      Hisashi Tanaka
    • 依托单位:
    国内基金
    海外基金
    17q21区域内发育性髋关节脱位易感基因的克隆、鉴定及功能研究
    • 批准号:
      30600654
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      22.0万元
    • 批准年份:
      2006
    • 负责人:
      李连永
    • 依托单位: